Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 24

Showing 24 citing articles:

Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Jing Chen, Wei Zhang, Yang Li, et al.
Cell (2025)
Closed Access | Times Cited: 6
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
Cell (2025)
Open Access | Times Cited: 5
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Young‐Jun Park, Chen Liu, Jimin Lee, et al.
Cell (2025)
Closed Access | Times Cited: 5
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 9
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Ellen Van Damme, Pravien Abeywickrema, Yanting Yin, et al.
Nature (2025)
Open Access | Times Cited: 1
Functional assessment of cell entry and receptor use for merbecoviruses
Nicholas Catanzaro, Ziyan Wu, Chengcheng Fan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses
Qing Xiong, Chengbao Ma, Chen Liu, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100145-100145
Open Access | Times Cited: 5
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
Cell Reports (2024) Vol. 43, Iss. 12, pp. 115036-115036
Open Access | Times Cited: 4
Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severity
Amy Sims, Alexandra Schaefer, Kenichi Okuda, et al.
mSphere (2025)
Open Access
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution
Chen Liu, Young‐Jun Park, Chengbao Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterization of a MERS-like betacoronavirus in Danish brown long-eared bats (Plecotus auritus)
Camille Melissa Johnston, Vithiagaran Gunalan, Hans J. Baagøe, et al.
(2025)
Closed Access
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael Mallory, Patrick O. Byrne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
Michael H. J. Rhodin, Archie C. Reyes, Anand Balakrishnan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Multiple Independent Acquisitions of ACE2 Usage in MERS-Related Coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
(2024)
Closed Access | Times Cited: 2
Recombination as an evolutionary driver of MERS-related coronavirus emergence
Jarel Elgin Tolentino, Spyros Lytras, Jumpei Ito, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e546-e546
Closed Access | Times Cited: 2
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
Mario A. Peña-Hernández, Mia Madel Alfajaro, Renata B. Filler, et al.
Nature Microbiology (2024) Vol. 9, Iss. 8, pp. 2038-2050
Closed Access | Times Cited: 2
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo
Nian Zhou, Su Tang, Xiangbing Bian, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114929-114929
Closed Access | Times Cited: 2
Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor
Hila Failayev, Assaf Ganoth, Yossi Tsfadia
Virus Research (2024) Vol. 342, pp. 199330-199330
Open Access | Times Cited: 1
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Marnix Van Loock, Ellen Van Damme, Pravien Abeywickrema, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Designed miniproteins potently inhibit and protect against MERS-CoV
Robert J. Ragotte, M. Alejandra Tortorici, Nicholas Catanzaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Identification of ACE2 as the Entry Receptor for Two Novel European Bat Merbecoviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
MERS-CoV Spike Vaccine-induced N-Terminal Domain-specific Antibodies are More Protective than Receptor Binding Domain-specific Antibodies
Olubukola M. Abiona, Nianshuang Wang, Sarah R. Leist, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111632-111632
Open Access
Page 1

Scroll to top